Success stories
The EyeGuard Study - Uveitis Treatment

Clinical Trial:

  • Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
  • Phase: 3
  • Geographical scope - Global
  • Investigative sites - 85+
  • Recruitment Goal - 300 patients
  • Study Deadline - January 1, 2015
  • Never Peak's Delivery - On time, under budget

Website:

www.eyeguard-study.com